Gloria Pharmaceuticals
closedHarbin Gloria Pharmaceuticals is engages in the research, development, production, and sale of pharmaceutical products.
Launch date
Employees
Market cap
$580m
Enterprise valuation
$536m (Public information from Sep 2024)
Share price
CNY1.86 002437.SZ
Harbin Heilongjiang (HQ)
Financials
Estimates*
| CNY | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 5.1b | 3.1b | 3.1b | 3.1b | 2.6b |
| % growth | - | - | - | (40 %) | 3 % | (1 %) | (16 %) |
| EBITDA | - | - | 502m | 934m | 301m | 18.5m | 340m |
| % EBITDA margin | - | - | 10 % | 31 % | 10 % | 1 % | 13 % |
| Profit | - | - | (2.7b) | 400m | 45.0m | (291m) | 120m |
| % profit margin | - | - | (53 %) | 13 % | 1 % | (9 %) | 5 % |
| EV / revenue | - | - | 1.6x | 2.5x | 2.0x | 1.9x | 2.1x |
| EV / EBITDA | - | - | 16.0x | 8.0x | 21.4x | 310.8x | 16.1x |
| R&D budget | - | - | 186m | 125m | 97.7m | 101m | 85.4m |
| R&D % of revenue | - | - | 4 % | 4 % | 3 % | 3 % | 3 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Gloria Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
ACQUISITION by Otsuka Pharmaceutical Dec 2020
